Fortis Healthcare reported strong financial results for Q2 2024, with significant improvements in operating profit, cash flow, net sales, and profit after tax. The company achieved its highest operating profit to interest ratio in five quarters and generated record operating cash flow of Rs 1,100.10 crore. Despite a low Debtors Turnover Ratio, the overall performance indicates promising growth, leading to a 'Buy' recommendation from MarketsMOJO.